MRVI1 Activators
MRVI1 Activators encompass a spectrum of chemical compounds that, through various signaling pathways, enhance the functional activity of MRVI1. Forskolin and Dibutyryl cAMP (db-cAMP), by increasing intracellular cAMP levels, indirectly augment MRVI1's activity by activating protein kinase A (PKA), which can phosphorylate MRVI1 or its associated proteins, thus modulating its role in cell signaling pathways. IBMX, by preventing the degradation of cAMP, and Rolipram, through PDE4 inhibition, synergistically enhance the cAMP/PKA signaling axis, further potentiating MRVI1 activation. PMA, as a PKC activator, and Epigallocatechin gallate (EGCG), a kinase inhibitor, modify the phosphorylation landscape within the cell, influencing MRVI1 activation directly or indirectly through associated pathways. LY294002, a PI3K inhibitor, may induce compensatory activation of alternate signaling routes involving MRVI1, while Genistein, by inhibiting tyrosine kinases, reduces competitive signaling, potentially liberating MRVI1 pathways to be more active.
In addition, FTY720, a sphingosine-1-phosphate receptor modulator, can impact actin cytoskeleton rearrangement, facilitating MRVI1's involvement in such processes. Ionomycin and A23187, both calcium ionophores, elevate intracellular calcium levels, triggering calcium-dependent protein activation and signaling pathways that could lead to the indirect activation of MRVI1. Thapsigargin, by inhibiting the SERCA pump, also increases intracellular calcium, similarly influencing calcium-signaling pathways linked to MRVI1 activity. Collectively, these MRVI1 Activators, through their targeted effects on signaling molecules and pathways, facilitate the enhancement of MRVI1's functional activity without necessitating the upregulation of its expression or direct activation, thereby acting as key modulators of MRVI1-mediated cellular functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which activates PKA. PKA can phosphorylate MRVI1, leading to its functional activation in pathways related to cell-cell adhesion and other cell signaling processes. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific phosphodiesterase inhibitor which prevents cAMP degradation, thus enhancing the activity of cAMP/PKA signaling axis. Increased PKA activity can subsequently lead to the activation of MRVI1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can modulate the phosphorylation status of MRVI1, resulting in its enhanced functional activity, particularly in cellular processes like migration and adhesion. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, activating calcium-dependent proteins and pathways that could lead to the functional activation of MRVI1 in cellular signaling. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit certain kinases, which could lead to reduced competition for substrates or downstream effectors, thereby enhancing signaling pathways in which MRVI1 is a component. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter AKT signaling, potentially causing a compensatory upregulation of alternative pathways involving MRVI1, leading to its activation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore similar to Ionomycin, increasing intracellular calcium levels and potentially activating MRVI1 through calcium-dependent signaling mechanisms. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which enhances cAMP levels in cells, thereby potentially increasing PKA activity and leading to the activation of MRVI1. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
FTY720 is a sphingosine-1-phosphate receptor modulator that can impact actin cytoskeleton rearrangement and could thereby enhance the function of MRVI1 in related cellular processes. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Db-cAMP is a cAMP analog that directly activates cAMP-dependent pathways, potentially leading to the activation of MRVI1 through downstream effects on PKA and related signaling cascades. | ||||||